MY189268A - Targeted/immunomodulatory fusion proteins and methods for making same - Google Patents
Targeted/immunomodulatory fusion proteins and methods for making sameInfo
- Publication number
- MY189268A MY189268A MYPI2018702239A MYPI2018702239A MY189268A MY 189268 A MY189268 A MY 189268A MY PI2018702239 A MYPI2018702239 A MY PI2018702239A MY PI2018702239 A MYPI2018702239 A MY PI2018702239A MY 189268 A MY189268 A MY 189268A
- Authority
- MY
- Malaysia
- Prior art keywords
- fusion proteins
- targeted
- methods
- making same
- immunomodulatory fusion
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 4
- 108020001507 fusion proteins Proteins 0.000 title abstract 4
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000006058 immune tolerance Effects 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates generally to the field of generating fusion proteins to be used in cancer therapy, and more specifically, to nucleotide sequences encoding the fusion proteins, wherein the chimeric fusion proteins comprises at least one targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2018702239A MY189268A (en) | 2013-03-13 | 2013-03-13 | Targeted/immunomodulatory fusion proteins and methods for making same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2018702239A MY189268A (en) | 2013-03-13 | 2013-03-13 | Targeted/immunomodulatory fusion proteins and methods for making same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY189268A true MY189268A (en) | 2022-01-31 |
Family
ID=82802152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2018702239A MY189268A (en) | 2013-03-13 | 2013-03-13 | Targeted/immunomodulatory fusion proteins and methods for making same |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY189268A (en) |
-
2013
- 2013-03-13 MY MYPI2018702239A patent/MY189268A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY174248A (en) | Targeted/immunomodulatory fusion proteins and methods for making same | |
| NZ711445A (en) | Fusion immunomodulatory proteins and methods for making same | |
| PH12015502087A1 (en) | Newcastle disease viruses and uses thereof | |
| MX2020012573A (en) | Chimeric antigen receptors targeting b-cell maturation antigen. | |
| PH12017500022A1 (en) | Carrier-antibody compositions and methods of making and using the same | |
| EP4603103A3 (en) | Chimeric neurotoxins | |
| WO2014145159A3 (en) | Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use | |
| NZ739133A (en) | Cellular targeted active ingredient delivery system | |
| MX344972B (en) | Immunostimulatory oligonucleotides. | |
| MX2017004039A (en) | Galnac phosphoramidites, nucleic acid conjugates thereof and their use. | |
| NZ733055A (en) | Anti-c10orf54 antibodies and uses thereof | |
| MX2016007541A (en) | Modified nucleic acid molecules and uses thereof. | |
| MX2015012334A (en) | Methods and compositions for weed control. | |
| MX2014003979A (en) | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof. | |
| EP4276200A3 (en) | Fgfr-tacc fusion proteins and methods thereof | |
| SG195114A1 (en) | Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use | |
| MX2020002544A (en) | Glycopyrrolate salts. | |
| MX2016004802A (en) | Anti-rsp02 and/or anti-rsp03 antibodies and their uses. | |
| PH12015501101B1 (en) | Method for eliciting an immune response to an immunogen | |
| GB201017519D0 (en) | Vaccines | |
| MX2015006616A (en) | Dual targeting. | |
| MX2015012281A (en) | Improved tnf binding proteins. | |
| MY189268A (en) | Targeted/immunomodulatory fusion proteins and methods for making same | |
| MY173515A (en) | Targeted/immunomodulatory fusion proteins and methods for making same | |
| MY191211A (en) | Targeted/immunomodulatory fusion proteins and methods for making same |